“Cartalax (20mg)” has been added to your cart. View cart
There are 31 results in total
Sort by:Date, new to old
-
TESA/IPA
$105.00Tesamorelin/Ipamorelin is a blend of two peptide research compounds for growth hormone pathway studies. -
TESA/IPA
$140.00Tesamorelin/Ipamorelin is a blend of two peptide research compounds for growth hormone pathway studies. -
TESA/IPA
$150.00Tesamorelin/Ipamorelin is a blend of two peptide research compounds for growth hormone pathway studies. -
-
-
BPC-157/TB-500 Blend
$110.00BPC-157/TB-500 Blend is a multi-peptide research compound blend for pathway interaction studies. -
BPC-157 Capsules
$125.00BPC-157 (Body Protection Compound-157) is a peptide research compound for signaling pathway studies. -
BPC-157
$65.00BPC-157 (Body Protection Compound-157) is a peptide research compound for signaling pathway studies. -
-
CJC-1295 no DAC (10mg)
$65.00CJC-1295 no DAC is a research peptide targeting GH signaling pathway studies. -
-
BPC-157
$45.00BPC-157 (Body Protection Compound-157) is a peptide research compound for signaling pathway studies. -
-
BPC-157 Capsules
$150.00BPC-157 (Body Protection Compound-157) is a peptide research compound for signaling pathway studies. -
BPC-157/TB-500 Blend
$75.00BPC-157/TB-500 Blend is a multi-peptide research compound blend for pathway interaction studies. -
GLOW (70mg)
$115.00GLOW is a multi-peptide research compound blend for pathway interaction studies. -
KLOW (80mg)
$150.00KLOW is a multi-peptide research compound blend for pathway interaction studies. -
Sermorelin (5mg)
$70.00Sermorelin is a peptide research compound for growth hormone pathway studies. -
Tesamorelin (10mg)
$90.00Tesamorelin is a peptide research compound for growth hormone pathway studies. -
CJC-1295 (no DAC) (5mg)+ Ipamorelin (5mg) Blend (10mg)
$85.00CJC-1295 (no DAC) + Ipamorelin is a dual-peptide research blend targeting GH signaling pathway studies. -
-
-
Thymosin Alpha-1 (10mg)
$85.00Thymosin Alpha-1 is a peptide research compound for immunomodulatory pathway studies. -
-
-
-
-
-
-














